Overall, this work postulates Sema4B as a new mediator involved in the inflammatory processes observed in patients with RA, pointing out the importance of class 4 semaphorins and PlexinB2 signalling in the pathogenesis of this disease. The gene discussed is SEMA4B; the disease is rheumatoid arthritis.